Research Webinar: Reprogramming The Immune System to Halt Myasthenia Gravis: Introduction to the COUR Nanoparticle Technology and Trial in MG
  • Set Text Size  
       

Events

MGFA Events Finder & Calendar

MGFA events serve to bring all of us across the MG Community together – whether online or in person. We are proud to offer conferences, seminars, and wellness and research webinars as well as fundraising events such as our MG Walks. We hope you will use this handy MGFA Events Finder List & Calendar to see upcoming or past events, and search for events that mean the most to you.

 

To view upcoming events, scroll down to see the events list or use the calendar on this page and click/tap on colored circle dates. You can also search for an event by typing the event name in the search bar. To view past events, type the name of the event in the search bar or click/tap the left arrow in the calendar.

Research Webinar: Reprogramming The Immune System to Halt Myasthenia Gravis: Introduction to the COUR Nanoparticle Technology and Trial in MG

By Nick Patrone
Event date: 8/20/2024 2:00 PM - 3:00 PM Export event

Reprogramming The Immune System to Halt Myasthenia Gravis: Introduction to the COUR Nanoparticle Technology and Trial in MG.

Tuesday, August 20, 2:00 PM EST / 11:00 AM PDT

Presented by: Dr. Paul Peloso

 

Register

 

At COUR, Dr. Paul Peloso, chief medical officer, is leading the development of a novel, groundbreaking technology that could reprogram the immune system and transform the treatment of myasthenia gravis (MG). COUR nanotechnology allows reprogramming of the immune system away from the destructive inflammatory response towards a more normal, housekeeping status. By infusing negatively charged nanoparticles that are packaged with portions of the antibodies that drive the negative effects in MG, that being the anti-ACH antibody, the immune system can be trained to reduce its destructive profile. Dr. Peloso's presentation will highlight the COUR technology and introduce the early clinical trial in generalized MG, offering new hope for more effective treatments and improved outcomes for patients.


Share this article

Print

A World Without MG

Donate Now